Pentraxin‐3: A new parameter in predicting the severity of diabetic foot infection?
- 15 February 2019
- journal article
- research article
- Published by Wiley in International Wound Journal
- Vol. 16 (3) , 659-664
Abstract
This study was undertaken to evaluate the diagnostic and prognostic values of pentraxin‐3 (PTX‐3) in patients with infected diabetic foot ulcers (IDFU) as well as to assess the association between PTX‐3 levels and IDFU severity. This study included 60 IDFU patients (Group 1), 45 diabetic patients without DFU (Group 2), and 45 healthy controls. Patients with IDFU were divided into mild, moderate, and severe subgroups based on classification of clinical severity. Patients who underwent amputation were also documented. Blood samples were collected to determine PTX‐3 levels. PTX‐3 levels in healthy controls, Group 1, and Group 2 were 5.83 (3.41‐20) ng/mL, 1.47 (0.61‐15.13) ng/mL, and 3.26 (0.67‐20) ng/mL, respectively. A negative correlation between plasma PTX‐3 and glucose levels was found. There were significant differences in terms of procalcitonin (PCT) and PTX‐3 levels in the subgroup analysis of Group 1. The PTX‐3 level in patients who did or did not undergo amputation was 4.1 (0.8‐13.7) and 1 (0.6‐15.1) ng/mL, respectively. Results suggest that PTX‐3 is a particularly effective marker in patients with IDFU, both in terms of predicting disease severity and assisting in the decision to perform amputation.Keywords
This publication has 31 references indexed in Scilit:
- Pentraxin 3 in the assessment of ventilator-associated pneumonia: An early marker of severityHeart & Lung, 2013
- Clinical Efficacy of the Pan Metatarsal Head Resection as a Curative Procedure in Patients with Diabetes Mellitus and Neuropathic Forefoot WoundsFoot & Ankle Specialist, 2012
- Seminar Review: A Review of the Basis of Surgical Treatment of Diabetic Foot InfectionsThe International Journal of Lower Extremity Wounds, 2011
- The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunityImmunological Reviews, 2008
- Guest Editorial: are diabetes‐related wounds and amputations worse than cancer?International Wound Journal, 2007
- Risk Factors for Foot Infections in Individuals With DiabetesDiabetes Care, 2006
- IFN-γ-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infectionMicrobes and Infection, 2005
- Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2004
- A report from the international consensus on diagnosing and treating the infected diabetic footDiabetes/Metabolism Research and Reviews, 2004
- Pathways to Diabetic Limb Amputation: Basis for PreventionDiabetes Care, 1990